Analyst consensus rating
aTyr Pharma Analyst Rating: none
Direct answer
aTyr Pharma's consensus rating is none.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $2.86.
Forecast evidence checked September 7, 2026.
Get free aTyr Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.50
- Average price target
- $2.86
- High price target
- $7.00
- Low price target
- $1.00
- Low target gap
- +101.1%
- Target upside
- +474.5%
- High target gap
- +1,307.6%
- Target range width
- 1,206.5%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for aTyr Pharma?
aTyr Pharma has a verified none consensus. The same dataset has an average price target of $2.86.
How far are aTyr Pharma's low and high targets from the recorded price?
The low target implies +101.1%, while the high target implies +1,307.6%.
How many analysts are included in aTyr Pharma's consensus?
The verified consensus includes 7 analysts.
How is aTyr Pharma's target upside or downside calculated?
The average target of $2.86 is divided by the recorded price of $0.50, then one is subtracted to produce +474.5%. This does not guarantee a future return.
When was aTyr Pharma's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.